قالب وردپرس درنا توس
Home / Business / The backs of the FDA panel extend the use of fish oil-derived medicine

The backs of the FDA panel extend the use of fish oil-derived medicine



An advisory panel recommended Thursday that the US Food and Drug Administration approve the extension of the use of a fish oil-derived drug to reduce the likelihood of heart attack and stroke in high-risk patients.

The panel of outside advisors voted 16 to 0 to enlarge the approved use of the drug, called Vascepa, from Amarin PLC. The FDA is not bound to follow the advice of its advisory committee, but it usually does.

The …


Source link